Microneedles may help light reach hard-to-treat skin cancers

Photodynamic therapy (PDT) uses a light-sensitive drug and a specific wavelength of light to destroy cancer cells. The treatment has become an important option for certain skin cancers because it can target diseased tissue while limiting damage to surrounding skin. But PDT has a fundamental challenge: both the drug and the light must reach the same area of tissue.

Microneedles are tiny structures, less than a millimeter (0.04 inches) in length, that painlessly pierce the skin’s outer barrier. Made from biodegradable polymers, they gradually dissolve after insertion.

Previous studies by the research group showed that microneedles loaded with aminolevulinic acid (ALA), a drug commonly used in PDT, delivered the treatment more deeply and evenly into skin tumors than traditional creams. This led to a more uniform production of the light-activated compound responsible for killing cancer cells upon light exposure.

Sign up for Blog Updates